Literature DB >> 6723886

Adenosine modulation of amygdala kindling.

M Dragunow, G V Goddard.   

Abstract

To test the hypothesis that kindling is restrained by the inhibitory neuromodulator, adenosine, the adenosine uptake blocker, papaverine, or the adenosine antagonist, aminophylline, were injected systemically into rats 20 min before each daily electrical stimulation of the amygdala. The effects on amygdala-triggered seizures of papaverine, adenosine, 2-chloroadenosine, and the adenosine antagonists, isobutylmethylxanthine and caffeine, were also investigated at seizure threshold. Papaverine inhibited kindling, whereas aminophylline accelerated kindling. The adenosine agonists had anticonvulsant effects on seizures, and the antagonists had proconvulsant effects which involved, primarily, the lengthening of afterdischarge duration. Aminophylline injected repeatedly, in the absence of electrical stimulation, induced seizures. These results support the hypothesis that adenosine can modulate kindling and affect the seizure process.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6723886     DOI: 10.1016/0014-4886(84)90212-7

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  10 in total

Review 1.  Presynaptic modulation controlling neuronal excitability and epileptogenesis: role of kainate, adenosine and neuropeptide Y receptors.

Authors:  João O Malva; Ana P Silva; Rodrigo A Cunha
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

Review 2.  Current prospects and challenges for epilepsy gene therapy.

Authors:  Marc S Weinberg; Thomas J McCown
Journal:  Exp Neurol       Date:  2011-10-08       Impact factor: 5.330

3.  Purines and the Anti-Epileptic Actions of Ketogenic Diets.

Authors:  Susan A Masino; Masahito Kawamura; David N Ruskin; Jeremy Gawryluk; Xuesong Chen; Jonathan D Geiger
Journal:  Open Neurosci J       Date:  2010-01-01

Review 4.  Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.

Authors:  Detlev Boison
Journal:  Epilepsy Res       Date:  2009-05-09       Impact factor: 3.045

5.  Novel N-methylated 8-oxoisoguanines from Pacific sponges with diverse neuroactivities.

Authors:  Tsuyoshi Sakurada; Martin B Gill; Shanti Frausto; Bryan Copits; Keiichi Noguchi; Keiko Shimamoto; Geoffrey T Swanson; Ryuichi Sakai
Journal:  J Med Chem       Date:  2010-08-26       Impact factor: 7.446

6.  Sleep improvement in dogs after oral administration of mioflazine, a nucleoside transport inhibitor.

Authors:  A Wauquier; H Van Belle; W A Van den Broeck; P A Janssen
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 7.  Physiological bases of the K+ and the glutamate/GABA hypotheses of epilepsy.

Authors:  Mauro DiNuzzo; Silvia Mangia; Bruno Maraviglia; Federico Giove
Journal:  Epilepsy Res       Date:  2014-04-21       Impact factor: 3.045

8.  Effects of chronic administration of adenosine A1 receptor agonist and antagonist on spatial learning and memory.

Authors:  D K Von Lubitz; I A Paul; R T Bartus; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1993-11-16       Impact factor: 4.432

Review 9.  Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation.

Authors:  Detlev Boison; Kerry-Ann Stewart
Journal:  Biochem Pharmacol       Date:  2009-08-12       Impact factor: 5.858

Review 10.  The Good, the Bad, and the Deadly: Adenosinergic Mechanisms Underlying Sudden Unexpected Death in Epilepsy.

Authors:  Benton Purnell; Madhuvika Murugan; Raja Jani; Detlev Boison
Journal:  Front Neurosci       Date:  2021-07-12       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.